| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $261.3M | $198.5M | $209.9M |
| YoY Revenue Growth % | +31.6% | -5.4% | — |
| Gross Profit | $78.0M | $33.0M | — |
| Gross Margin % | 29.8% | 16.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$26.6M | -$65.6M | -$46.8M |
| Operating Margin % | -10.2% | -33.1% | -22.3% |
| Net Income (GAAP) | -$23.5M | -$60.8M | -$41.7M |
| EBITDA (Normalized) | -$19.3M | -$59.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $21.3M | -$2.4M | $10.1M |
| Capital Expenditures (CapEx) | $9.0M | $7.9M | — |
| Free Cash Flow (FCF) | $12.3M | -$10.3M | $10.1M |
| FCF Margin % | 4.7% | -5.2% | 4.8% |
| Return on Invested Capital (ROIC %) | -16.4% | -34.4% | — |
| Cash & Short-Term Equivalents | $98.7M | $65.8M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $226.7M | $216.4M | — |